Regional distribution of proteinase K-resistant alpha-synuclein correlates with Lewy body disease stage. (Q53875651)

21 May 2018

title

Regional distribution of proteinase K-resistant alpha-synuclein correlates with Lewy body disease stage. (English)

1 reference

21 May 2018

1 reference

1

Manuela Neumann

1 reference

21 May 2018

4

Christian Haass

1 reference

21 May 2018

author name string

Veronika Müller

series ordinal

2

1 reference

21 May 2018

Hans A Kretzschmar

series ordinal

3

1 reference

21 May 2018

Philipp J Kahle

series ordinal

5

1 reference

21 May 2018

publication date

1 December 2004

1 reference

21 May 2018

Journal of Neuropathology & Experimental Neurology

published in

1 reference

21 May 2018

volume

63

1 reference

21 May 2018

issue

12

1 reference

21 May 2018

page(s)

1225-1235

1 reference

21 May 2018

Alpha-synuclein and presynaptic function: implications for Parkinson's disease.

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.12.1225

Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.12.1225

Oxidative stress induces amyloid-like aggregate formation of NACP/alpha-synuclein in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.12.1225

Both familial Parkinson's disease mutations accelerate alpha-synuclein aggregation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.12.1225

Synergistic effects of pesticides and metals on the fibrillation of alpha-synuclein: implications for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.12.1225

alpha-Synuclein is phosphorylated in synucleinopathy lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.12.1225

A Drosophila model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.12.1225

Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.12.1225

Neuronal alpha-synucleinopathy with severe movement disorder in mice expressing A53T human alpha-synuclein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.12.1225

Human alpha-synuclein-harboring familial Parkinson's disease-linked Ala-53 --> Thr mutation causes neurodegenerative disease with alpha-synuclein aggregation in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.12.1225

Misfolded proteinase K-resistant hyperphosphorylated alpha-synuclein in aged transgenic mice with locomotor deterioration and in human alpha-synucleinopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.12.1225

Motor dysfunction and gliosis with preserved dopaminergic markers in human alpha-synuclein A30P transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.12.1225

Alpha-synuclein in Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.12.1225

Lewy body in neurodegeneration with brain iron accumulation type 1 is immunoreactive for alpha-synuclein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.12.1225

NACP/alpha-synuclein immunoreactivity in fibrillary components of neuronal and oligodendroglial cytoplasmic inclusions in the pontine nuclei in multiple system atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.12.1225

Accumulation of alpha-synuclein/NACP is a cytopathological feature common to Lewy body disease and multiple system atrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.12.1225

Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.12.1225

Neuropathology of synuclein aggregates

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.12.1225

Alpha-synuclein and neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.12.1225

Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.12.1225

Report of the second dementia with Lewy body international workshop: diagnosis and treatment. Consortium on Dementia with Lewy Bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.12.1225

Staging of brain pathology related to sporadic Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.12.1225

Alpha-synuclein-immunoreactive cortical Lewy bodies are associated with cognitive impairment in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.12.1225

Axon pathology in Parkinson's disease and Lewy body dementia hippocampus contains alpha-, beta-, and gamma-synuclein

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.12.1225

Degenerative terminals of the perforant pathway are human alpha-synuclein-immunoreactive in the hippocampus of patients with diffuse Lewy body disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.12.1225

Novel antibodies to synuclein show abundant striatal pathology in Lewy body diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.12.1225

Biochemical characterization of the core structure of alpha-synuclein filaments

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.12.1225

Selective insolubility of alpha-synuclein in human Lewy body diseases is recapitulated in a transgenic mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.12.1225

alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.12.1225

Oxidative dimer formation is the critical rate-limiting step for Parkinson's disease alpha-synuclein fibrillogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.12.1225

Ubiquitination of a new form of alpha-synuclein by parkin from human brain: implications for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.12.1225

Phosphorylated alpha-synuclein is ubiquitinated in alpha-synucleinopathy lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.12.1225

Aggregated and monomeric alpha-synuclein bind to the S6' proteasomal protein and inhibit proteasomal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.12.1225

Altered proteasomal function in sporadic Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.12.1225

Misfolded, protease-resistant proteins in animal models and human neurodegenerative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.12.1225

21 January 2018

Identifiers

DOI

10.1093/JNEN/63.12.1225

1 reference

21 May 2018

PubMed ID

15624759

1 reference

21 May 2018